If youre ready to move from feeling run-down to revitalized, youre not alone, and youre not stuck
GLP-1 achieves this mainly by stimulating insulin secretion and inhibiting the release of glucagon [2]
Novel antidiabetic therapies, including sodium glucose cotransporter 2 inhibitors (SGLT2i), glucagonlike peptide-1 receptor agonists (GLP-1 RA), and glucosedependent insulinotropic polypeptide (GIP)/glucagonlike peptide-1 (GLP-1) dual receptor agonists, have demonstrated clear efficacy in the management of MetS [9,10,11]
For type 2 diabetes (Ozempic), the recommended maintenance doses are 0.5 mg, 1 mg, or 2 mg administered subcutaneously once weekly
Results usually take 24 weeks of consistent use, especially when combined with proper diet and exercise